Hugel secures the domestic sales rights for ECM-based injectable CellREDM, planning collaboration with Hans Biomed The company aims to create synergies with its botulinum toxin and dermal filler products as a new growth engine SEOUL, South Korea, March 31, 2026 /PRNewswire/ -- Hugel Inc.,...
Hence then, the article about hugel to enter ecm based injectable market with aesthetic portfolio expansion was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hugel to enter ECM-based injectable market with aesthetic portfolio expansion )
Also on site :
- Hezbollah Denies Bahraini Interior Ministry& 039;s Baseless Allegations
- This 30-Year-Old Start to a Book Series Is Named the Best Epic Fantasy on Goodreads
- New Study Claims That Traveling Regularly Can Actually Help You Live Longer